Layout A

Video

Clonal evolution of tumours

Tumors are usually of clonal origin, that is, they arise from a single cell. The monoclonality of tumors can be seen, for example, in multiple myeloma, a tumor of the plasma cells. In serum protein electrophoresis, antibodies migrate mainly in the gamma globulin fraction. Antibodies are...

Read More

Layout A (slider)

Video

Clonal evolution of tumours

Tumors are usually of clonal origin, that is, they arise from a single cell. The monoclonality of tumors can be seen, for example, in multiple myeloma, a tumor of the plasma cells. In serum protein electrophoresis, antibodies migrate mainly in the gamma globulin fraction. Antibodies are...

Read More
Video

Molecular action of p53 in carcinogenesis

The tumor suppressor protein p53 is a transcription factor. p53 monomers assemble into tetramers that bind to consensus sequences in the DNA and activate the transcription of p53 response genes. P53 target genes are involved in the regulation of proliferation, apoptosis and genomic...

Read More
Video

Apoptosis

The term apoptosis describes the regulated and gradual death of a cell. In contrast to uncontrolled necrosis, apoptosis is limited to one or a few cells and is not accompanied by inflammation. Through apoptosis, the organism can get rid of cells, which are non-functional or which are...

Read More
Video

The EGF receptor tyrosine protein kinases

The most important family of receptor tyrosine kinases is the family of the receptors for EGF (Epidermal Growth Factor). Activation of the EGF receptor tyrosine kinase by extracellular EGF results in its dimerization and its autophosphorylation on its cytosolic domains. The phosphorylated...

Read More
Video

The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors – Part 1: Inhibition of receptor activation via antibodies

In many tumors, EGF receptors are over-activated, which leads to a stronger signal and a high rate of proliferation. In order to inhibit the signal and to reduce the rate of proliferation, the EGF receptors can be inhibited by antibodies. Prominent examples are Cetuximab and Trastuzumab...

Read More
Video

The EGF receptor tyrosine protein kinases and the therapy of tumors with activated EGF receptors – Part 2: Blocking of EGF receptor signaling via tyrosine kinase inhibitors

Tumors with activated EGF receptors can be treated with drugs that inhibit the kinase activity by binding to intracellular domains. Most of these drugs are ATP analogs that block ATP binding and thus prevent auto- and transphosphorylation by the intracellular receptor domains. Mutations...

Read More

Layout A (combined with B)

Video

Clonal evolution of tumours

Tumors are usually of clonal origin, that is, they arise from a single cell. The monoclonality of tumors can be seen, for example, in multiple myeloma, a tumor of the plasma cells. In serum protein electrophoresis, antibodies migrate mainly in the gamma globulin fraction. Antibodies are...

Read More

Layout A (with pagination)

Video

Clonal evolution of tumours

Tumors are usually of clonal origin, that is, they arise from a single cell. The monoclonality of tumors can be seen, for example, in multiple myeloma, a tumor of the plasma cells. In serum protein electrophoresis, antibodies migrate mainly in the gamma globulin fraction. Antibodies are...

Read More
Video

Molecular action of p53 in carcinogenesis

The tumor suppressor protein p53 is a transcription factor. p53 monomers assemble into tetramers that bind to consensus sequences in the DNA and activate the transcription of p53 response genes. P53 target genes are involved in the regulation of proliferation, apoptosis and genomic...

Read More